Abstract
Background
Guidelines are intended to facilitate evidence-based clinical decision-making and knowledge translation; however, the quality and rigor of the guidelines are different. This study was conducted to assess the quality of sublingual immunotherapy guidelines for allergic rhinitis, in order to provide a reference for evidence-based clinical treatment and management of sublingual immunotherapy.
Methods
Using both Chinese and English search methods, articles were obtained from PubMed, Cochrane, Web of Science, CNKI, CBM, WanFang Data, VIP, and other databases from the construction of the database to September 2020. The AGREE II instrument was used by two researchers to independently evaluate the quality of the extracted articles, and the consistency of the researchers was evaluated using the inter-group correlation coefficient.
Results
Ten articles were included in this study, of which two articles ranked A level, six articles ranked B level, and two articles ranked C level. The six sections of AGREE II included scope and aim, clarity, participant, applicability, rigor, and editorial independence, with standardized scores of 78.06%, 45.83%, 42.81%, 77.50%, 50.42%, and 46.25%, respectively.
Conclusion
The quality of the current guidelines for sublingual immunotherapy is average. The formulation methodology and reporting standards of these guidelines must be developed. By standardizing the treatment of sublingual immunotherapy properly, it is recommended that guideline makers refer to the AGREE II to formulate high-quality guidelines and promote their wide application.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, Shifan Han, upon reasonable request.
References
Bousquet J, Schünemann HJ, Togias A et al (2020) Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol 145:70–80
Chan AW, Luk WP, Fung LH et al (2019) The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions. Immunotherapy 11:1387–1397
Novakova SM, Novakova PI, Yakovliev PH et al (2018) A Three-year course of house dust mite sublingual immunotherapy appears effective in controlling the symptoms of allergic rhinitis. Am J Rhinol Allergy 32:147–152
Cox LS (2017) Sublingual immunotherapy for allergic rhinitis: is 2-year treatment sufficient for long-term benefit? JAMA 317:591
Deng Y, Luo L, Hu Y et al (2016) Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC Anesthesiol 16:12
Rodriguez-Martinez CE, Sossa-Briceño MP, Acuña-Cordero R (2017) Quality assessment of acute viral bronchiolitis clinical practice guidelines. J Eval (Clin Pract) 23:37–43
Brouwers MC, Kerkvliet K, Spithoff K (2016) The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 352:i1152
Shallwani SM, King J, Thomas R et al (2019) Methodological quality of clinical practice guidelines with physical activity recommendations for people diagnosed with cancer: a systematic critical appraisal using the AGREE II tool. PLoS ONE 14:e0214846
Lei C, Zhen D, Wei K (2015) Guidelines for the diagnosis and treatment of allergic rhinitis (2015, Tianjin). International Journal of Otolaryngology-Head and Neck Surgery 51(1):6–24
Canonica GW, Cox L, Pawankar R et al (2014) Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 7:6
Jutel M, Bartkowiak EM, Bręborowicz A et al (2016) Sublingual immunotherapy (SLIT)—indications, mechanism, and efficacy Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy. Ann Agric Environ Med 23:44–53
Walker SM, Durham SR, Till SJ et al (2011) Immunotherapy for allergic rhinitis. Clin Exp Allergy 41:1177
Gaur SN, Kumar R, Singh AB, Agarwal MK, Arora N (2019) Guidelines for practice of allergen immunotherapy in India: 2017-an update. Clin Allergy 21(437):3
Halken S, Larenas-Linnemann D, Roberts G et al (2017) EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol 28:728–745
Seidman MD, Gurgel RK, Lin SY et al (2015) Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152:197–206
Li H, Chen S, Cheng L et al (2019) Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma. J Thorac Dis 11:4936–4950
Masuyama K, Goto M, Takeno S et al (2016) Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients. Auris Nasus Larynx 43:1–9
Cheng L, Chen J, Fu Q et al (2018) Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res 10:300–353
Hoffmann-Eer W, Siering U, Neugebauer E et al (2018) Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use. BMC Health Servs Res 18:143
Seto K, Matsumoto K, Kitazawa T et al (2017) Evaluation of clinical practice guidelines using the AGREE instrument: comparison between data obtained from AGREE I and AGREE II. BMC Res Notes 10:716
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Q., Zhu, R., Ning, Y. et al. Evaluation of the quality of guidelines for sublingual immunotherapy of allergic rhinitis. Eur Arch Otorhinolaryngol 280, 4319–4325 (2023). https://doi.org/10.1007/s00405-023-08083-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08083-w